46Y-19318-53515
3 vaccinations
3 coded responses
34 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 229 / VA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
WWA-19234-85030
Child or adolescent in my care · Male · 2022-07-22
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2020-12-28
-
2020-12-29
Health check-in — day 7, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-01-05
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Itching · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-15
- 2021-01-16
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-10-05
Dose 3 — Pfizer-BioNTech
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-07
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Oedema peripheral — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Pain and swelling in axilla of injection armMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-09
-
2021-10-10
Survey response — days 1–6 daily, dose 3MedDRA: Dyspnoea — Feeling: GoodFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
- 2021-10-11
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2022-01-04
-
2022-04-05
Survey response — 6 months, dose 3MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy · Healthcare visit (other): Routine prenatal careMedDRA releases: 2024-11 · check-in free text available
-
2022-04-05
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-04-06
- 2022-10-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-13 | priority 2/3 | |
| 2021-01-14 | priority 2/3 | |
| 2022-04-05 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Pain and swelling in axilla of injection arm
Systemic reaction (other): Shortness of breath
Release 11 — 6 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release